AT1 receptor agonistic antibodies, hypertension, and preeclampsia.

[1]  F. Luft Pre-eclampsia and the maternal cardiovascular risk. , 2003, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

[2]  G. Wallukat,et al.  AT1 Receptor Agonistic Antibodies From Preeclamptic Patients Stimulate NADPH Oxidase , 2003, Circulation.

[3]  A. Luttun,et al.  Soluble VEGF receptor Flt1: the elusive preeclampsia factor discovered? , 2003, The Journal of clinical investigation.

[4]  T. Libermann,et al.  Excess placental soluble fms-like tyrosine kinase 1 (sFlt1) may contribute to endothelial dysfunction, hypertension, and proteinuria in preeclampsia , 2003 .

[5]  K. Conrad,et al.  Impaired Oxygen-dependent Reduction of HIF-1α and -2α Proteins in Pre-eclamptic Placentae , 2003 .

[6]  K. Conrad,et al.  Impaired oxygen-dependent reduction of HIF-1alpha and -2alpha proteins in pre-eclamptic placentae. , 2003, Placenta.

[7]  Y. Pinto,et al.  Increased expression of cardiac angiotensin II type 1 (AT(1)) receptors decreases myocardial microvessel density after experimental myocardial infarction. , 2003, Cardiovascular research.

[8]  G. Wallukat,et al.  Agonistic autoantibodies directed against the angiotensin II AT1 receptor in patients with preeclampsia. , 2003, Canadian journal of physiology and pharmacology.

[9]  S. Bobst,et al.  Maternal Autoantibodies From Preeclamptic Patients Active Angiotensin Receptors on Human Trophoblast Cells , 2003, The Journal of the Society for Gynecologic Investigation: JSGI.

[10]  J. Pouysségur,et al.  Induction of Hypoxia-inducible Factor-1α by Transcriptional and Translational Mechanisms* , 2002, The Journal of Biological Chemistry.

[11]  R. Hetzer,et al.  Specific Removal of β1-Adrenergic Autoantibodies from Patients with Idiopathic Dilated Cardiomyopathy , 2002 .

[12]  R. Schmieder,et al.  Angiotensin Converting Enzyme Inhibition and Angiotensin II AT1-Receptor Blockade Reduce the Levels of Asymmetrical NG, NG-Dimethylarginine in Human Essential Hypertension* , 2002 .

[13]  H. Lother,et al.  Increased AT1 receptor heterodimers in preeclampsia mediate enhanced angiotensin II responsiveness , 2001, Nature Medicine.

[14]  D. Ganten,et al.  Rats transgenic for human renin and human angiotensinogen as a model for gestational hypertension. , 2000, Journal of the American Society of Nephrology : JASN.

[15]  K. Rahn,et al.  Membrane, intracellular, and plasma magnesium and calcium concentrations in preeclampsia. , 2000, American journal of hypertension.

[16]  G. Wallukat,et al.  Autoantibodies against the angiotensin receptor (AT1) in patients with hypertension , 2000, Journal of hypertension.

[17]  G. Wallukat,et al.  AT(1) receptor agonistic antibodies from preeclamptic patients cause vascular cells to express tissue factor. , 2000, Circulation.

[18]  M. Post,et al.  Inhibition of TGF-beta 3 restores the invasive capability of extravillous trophoblasts in preeclamptic pregnancies. , 1999, The Journal of clinical investigation.

[19]  G. Wallukat,et al.  Patients with preeclampsia develop agonistic autoantibodies against the angiotensin AT1 receptor. , 1999, The Journal of clinical investigation.

[20]  M. Drab,et al.  Endothelial-cell permeability and protein kinase C in pre-eclampsia , 1998, The Lancet.

[21]  K. Thomas,et al.  Determination of renin, angiotensin converting enzyme and angiotensin II levels in human placenta, chorion and amnion from women with pregnancy induced hypertension , 1996, Clinical endocrinology.

[22]  P. Chiale,et al.  Molecular mimicry between the immunodominant ribosomal protein P0 of Trypanosoma cruzi and a functional epitope on the human beta 1- adrenergic receptor , 1995, The Journal of experimental medicine.

[23]  H. Haller,et al.  Increased intracellular free calcium and sensitivity to angiotensin II in platelets of preeclamptic women. , 1989, American journal of hypertension.

[24]  S. Chand,et al.  A study of angiotensin II pressor response throughout primigravid pregnancy. , 1973, The Journal of clinical investigation.

[25]  G. Wallukat,et al.  Immunohistochemical localization of angiotensin II receptors (AT1) in the heart with anti-peptide antibodies showing a positive chronotropic effect. , 1998, Receptors & channels.

[26]  A. Busjahn,et al.  Endothelial adhesion molecules and leukocyte integrins in preeclamptic patients. , 1997, Hypertension.

[27]  G. Wallukat,et al.  Anti-beta 1-adrenoceptor autoantibodies with chronotropic activity from the serum of patients with dilated cardiomyopathy: mapping of epitopes in the first and second extracellular loops. , 1995, Journal of molecular and cellular cardiology.